Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis

Data regarding effectiveness and safety of ocrelizumab in the post-marking setting are lacking. The aim of our study was to provide effectiveness and safety data of ocrelizumab treatment in patients with relapsing–remitting (RR-) and progressive multiple sclerosis (PMS) and to evaluate clinical and...

Descripción completa

Detalles Bibliográficos
Autores principales: Cellerino, Maria, Boffa, Giacomo, Lapucci, Caterina, Tazza, Francesco, Sbragia, Elvira, Mancuso, Elisabetta, Bruschi, Nicolò, Minguzzi, Simona, Ivaldi, Federico, Poirè, Ilaria, Laroni, Alice, Mancardi, Gianluigi, Capello, Elisabetta, Uccelli, Antonio, Novi, Giovanni, Inglese, Matilde
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457546/
https://www.ncbi.nlm.nih.gov/pubmed/34553320
http://dx.doi.org/10.1007/s13311-021-01104-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457546/
https://www.ncbi.nlm.nih.gov/pubmed/34553320
http://dx.doi.org/10.1007/s13311-021-01104-8

Ejemplares similares